ArticleMolecular therapy. Oncology2026

Engineering fratricide-resistant CCR4/CD7 CAR T cells with enhanced safety and persistence for T cell malignancies.

Sile Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.